TY  - CHAP
M1  - Book, Section
TI  - Gastroesophageal Reflux Disease
A1  - Prunty, Jeremy J.
A1  - Prunty, Leesa M.
A2  - Chisholm-Burns, Marie A.
A2  - Schwinghammer, Terry L.
A2  - Malone, Patrick M.
A2  - Kolesar, Jill M.
A2  - Bookstaver, P. Brandon
A2  - Lee, Kelly C.
Y1  - 2022
N1  - 
T2  - Pharmacotherapy Principles & Practice, 6e
AB  - LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Explain  the  underlying  causes  of  gastroesophageal  reflux  disease  (GERD).Understand  the  difference  between  typical,  atypical,  and  alarm  symptoms.Determine  when  diagnostic  tests  should  be  recommended  based  on  the  clinical  presentation.Identify  the  desired  therapeutic  outcomes  for  patients  with  GERD.Recommend  appropriate  nonpharmacologic  and  pharmacologic  interventions  for  patients  with  GERD.Educate  patients  on  appropriate  lifestyle  modifications  and  drug  therapy  issues  including  adherence,  adverse  effects,  and  drug  interactions.Formulate  a  monitoring  plan  to  assess  the  effectiveness  and  safety  of  pharmacotherapy  for  GERD.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/10/10
UR  - ppp.mhmedical.com/content.aspx?aid=1187008552
ER  -